Topical sensitizers in alopecia areata.
Though many therapies exist for alopecia areata, one of the most unique is topical sensitization. By altering the pathogenic inflammatory response with few side effects, sensitizers offer an attractive treatment option for many patients with alopecia areata, including those who have previously failed more traditional treatments and those who have extensive disease.
McMichael
Amy J
AJ
Hair Disorders Clinic, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Henderson
Robert L
RL
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000279:Administration, Cutaneous; D000506:Alopecia Areata / Q000188:drug therapy* / Q000276:immunology; D003503:Cyclobutanes / Q000627:therapeutic use; D003521:Cyclopropanes / Q000276:immunology / Q000627:therapeutic use; D004137:Dinitrochlorobenzene / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation; D007509:Irritants / Q000276:immunology / Q000627:therapeutic use*; D018579:Patient Selection; D011379:Prognosis; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; D003521:Cyclopropanes; D004137:Dinitrochlorobenzene; D007509:Irritants; C020637:squaric acid dibutyl ester; C029402:diphenylcyclopropenone